See every side of every news story

Published 6 hours ago • loading... • Updated 6 hours ago

Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for ...

Summary by Enid News & Eagle

REYKJAVIK, Iceland, Aug. 21, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced a strategic licensing and commercialization agreement with Lotus Pharmaceutical (TWSE…

4 Articles

4 Articles

Enid News & Eagle

Reposted by

pmg-ky3.com

Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for ...

REYKJAVIK, Iceland, Aug. 21, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced a strategic licensing and commercialization agreement with Lotus Pharmaceutical (TWSE…

6 hours ago

Read Full Article

Reposted by

stocktitan.net

Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets

REYKJAVIK, Iceland, Aug. 21, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology

6 hours ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources4

Leaning Left1Leaning Right0Center1Last Updated1 hour agoBias Distribution

50% Left, 50% Center

Bias Distribution

50% of the sources lean Left, 50% of the sources are Center

50% Center

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

WBOC 16 broke the news 6 hours ago on Friday, August 21, 2026.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics